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ABSTRACT 
An excellent monitor of the immune balance of peripheral circulating cells is to determine their cytokine 
production patterns in response to stimuli. Using flow cytometry a positive identification of cytokine producing 
cells in a mixed culture may be achieved. Recently, the ability to assess cytokine production following a whole-
blood activation culture has been described. We compared whole blood culture to standard PBMC culture and 
determined the individual cytokine secretion patterns for both T cells and monocytes via flow cytometry. For T 
cells cytokine assessment following PMA +ionomycin activation: (1) a significantly greater percentages of T cells 
producing IFNyand IL-2 were observed following whole-blood culture; (2) altered T cell cytokine production 
kinetics were observed by varying whole blood culture times. In addition, a four-color cytometric analysis was 
used to allow accurate phenotyping and quantitation of cytokine producing lymphocyte populations. Using this 
technique we found IFNy production to be significantly elevated in the CD3+/CD8+ T cell population as 
compared to the CD3+/CD8- population following five hours of whole blood activation. Conversely, IL-2 and IL-
10 production were significantly elevated in the CD3+/CD8- T cell population as compared to the CD3+/CD8+ 
population. Monocyte cytokine production was assessed in both culture systems following LPS activation for 
24 hours. A three-color flow cytometric was used to assess two cytokines in conjunction with CD 14. The 
cytokine pairs used for analysis were IL-1a/IL-12, and IL-10ITNFa. Nearly all monocytes were stimulated to 
produce IL-1a, IL-12 and TNFa equally well in both culture systems. Monocyte production of IL-10 was 
significantly elevated following whole blood culture as compared to PBMC culture. IL-12 producing monocytes 
appeared to be a distinct subpopulation of the IL-1a producing set, whereas IL-10 and TNFa producing 
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monocytes were largely mutually exclusive. IL-10 and TNFa producing monocytes may represent functionally 
different monocyte subsets with distinct functions. Whole blood culture eliminates the need to purify cell 
populations prior to culture and may have significant utility for the routine monitoring of the cytokine balances of 
the peripheral blood T cell and monocyte populations. In addition, there are distinct advantages to performing 
whole-blood (WB) activation as compared to PBMC activation. These advantages would include retaining all 
various cell-cell interactions as well as any soluble factors present in serum that influence cell activation. It is 
likely that the altered cytokine production observed following whole blood culture more accurately represents the 
in-vivo immune balance. 
INTRODUCTION 
The role of the immune system and cytokine regulation in the development and progression of a variety of 
disease states has been well defined. Correspondingly, improved techniques to evaluate cytokine production 
have been developed. The emergence of flow cytometric detection of intracellular cytokine production has 
occurred over the last decade and offers several unique advantages over most standard cytokine detection 
methods (1-6). Using multicolor staining techniques, the detection of several cytokines in conjunction with 
multiple surface markers now offers the ability to completely phenotype cytokine producing cells. Since protein 
secretion is abrogated as part of the detection process, bystander cellular activation is significantly reduced 
offering a clearer presentation of the true cytokine bias of the various cellular populations. The clinical utility of 
cytokine detection by flow cytometry has been recently demonstrated for several disease states (7-9) and new 
developments were recently reviewed by Maino et al (10). Since this technique is relatively simple to perform 
with equipment already standard in many hospitals the routine clinical use of peripheral blood cytokine profiles 
to monitor the both the magnitude and direction of peripheral immune activation is likely to emerge. A potential 
drawback of standard cytokine detection by flow cytometry following PBMC culture is a relatively low sensitivity 
with respect to some cytokines. In addition, whole blood culture techniques have recently been introduced 
which facilitate analysis and may more accurately reflect in-vivo immune than does PBMC culture. 
We have compared whoie blood culture to standard PBMC culture techniques with regards to cytokine 
detection by flow cytometry for both T cells and monocytes. A variety of cytokines were analyzed and varied 
culture times were investigated. Multicolor analysis was used to investigate cytokine producing cell sub-
populations. The data demonstrate the advantages of whole blood culture for routine cl inical monitoring of 
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cytokine regulation by flow cytometry. 
MATERIALS AND METHODS 
Blood donors. Whole blood samples were obtained from adult donors into ACD or sodium heparin 
anticoagulant vacutainers. The subjects had been screened by the NASA-JSC Test Subject Facility for most 
major infectious diseases and were found to be in good health. Institutional Review Board (NASA-JSC) 
approval was obtained for this study and writt~n informed consent was obtained from all subjects. 
Peripheral mononuclear cell isolation. For PBMC isolation, 4.0 ml of whole ACD anticoagulated blood was 
diluted 1:1 with sterile phosphate buffered saline (PBS) and subjected to centrifugation over a Ficoll-Hypaque 
density gradient (Pharmacia, Upsala Sweden). The isolated cells were washed 3 times in sterile PBS and 
resuspended in RPMI medium 1640 (Gibco BRL, Grand Island, NY) containing 10% fetal bovine serum 
(GIBCO) and 1 x 105 mg/ml penicillin and streptomycin (GIBCO). The final concentration of cells was 
determined using a hemacytometer. A final concentration of approximately 1.0 x 106 cellslml was used in all 
PBMC activation experiments. 
PBMC culture conditions for activation. For PBMC T cell activation, isolated cells were cultured in RPMI 
medium 1640 (Gibeo BRL) containing 10 nglml phorbol myristate acetate (PMA- Sigma, St. Louis, MO) and 2 
Ilgtml ionomycin (Sigma). The cells were cultured for the indicated length of time (5 or 24 hours). In all cases 3 
IlM monensin (Sigma) was added to the medium for the final five hours to abrogate extracellular transport of 
cytokines and allow intracellular accumulation (11). The cells were fixed in 4.0% paraformaldehyde and then 
washed 3 times in sterile PBS prior to staining. For PBMC monocyte activation the cells were cultured in RPM I 
medium 1640 (Gibco BRL) containing 10 mglml LPS (Sigma, St. Louis, MO) and 3 mM monensin (Sigma) for 24 
hours. The cells were then fixed in 4.0% paraformaldehyde and then washed 3 times in sterile PBS prior to 
staining. 
Whole blood 'culture conditions for activation. For whole blood T cell activation, 50111 of heparinized whole 
blood was added to 1.0 ml of RPMI medium 1640 (Gibco BRL) containing 100 nglml PMA (Sigma, St.Louis, 
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MO) and 2 Ilgtml ionomycin (Sigma) to create a 1 :20 dilution of whole blood in medium. Cells were cultured for 
-the indicated length of time (5 or 24 hours). In all cases 3 IlM monensin (Sigma) was added to the medium for 
the final five hours to allow cytokine accumulation. Following activation the RBCs were lysed using FACSlyse 
(Becton-DiCkinson, Mountain View, CA) according to the manufacturers instructions. The cells were fixed in 
4.0% paraformaldehyde and then washed 3 times in sterile PBS prior to staining. For whole blood monocyte 
activation 300ml of heparinized whole blood was added to 2.0 ml of RPMI medium 1640 (Gibco BRL) containing 
10 mglml LPS (Sigma, St. Louis, MO) and 3 mM monensin (Sigma) for 24 hours. Following activation the RBCs 
were lysed using FACSlyse (Becton-Dickinson, Mountain View, CAl according to the manufacturers instructions. 
The cells were fixed in 4.0% paraformaldehyde and then washed 3 times in sterile PBS prior to staining . . 
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Fluorescent antibody staining. Following fixation, the cells were then washed 3 times in PBS. To detect 
intracellular production cytokine in conjunction with a surface marker (both culture conditions), the fixed cells 
were resuspended in 200 ~I of permeabilization buffer, consisting of 5.0% non-fat dry milk and 0.5% saponin in 
PBS containing 0.5 ~g of each labeled antibody. The antibody combination for each tube (with manufacturers) 
is presented in table 1. The cells were incubated at room temperature for 60 minutes and then washed in PBS 
containing 0.5% saponin. The cells were then resuspended in 1.0% paraformaldehyde for analysis. 
Flow cytometry analysis . For analysis, a Coulter XL flow cytometer was conf igured for four color analysis with 
appropriate electronic compensation for spectral overlap of the light emitted by the different fluorochromes. The 
target cells (CD3+ T cells or CD14+ monocytes) were then 'gated' for immunofluorescence analysis, including 
only the target cells in the data analysis. Thresholds for positive were set using isotype matched control 
antibodies or internal cells distinctly negative for the target antigens. 
RESULTS 
T cell cytokine expression is altered following whole blood activation. T cell cytokine production following 
whole-blood activation was compared to T cell cytokine production following PBMC activation. PBMCs were 
activated for 5 hours in medium containing 10 ng/ml PMA, 2 ug/ml ionomycin and 3j.lM monensin, whereas 
whole blood (1 :20 in medium) was activated for 5 hours in medium containing 100 ng/ml PM A, 2 ug/ml 
ionomycin and 3)lM monensin. For this comparison the readily detectable pro-inflammatory cytoklnes IFNg and 
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IL-2 were assessed. The data showed that for each donor both cytokines were expressed on significantly 
greater percentages of T cells (CD3+) in the whole blood cultures as compared to the PBMC cultures. The 
mean percentages (four experiments) of cytokine producing T cells for each culture condition are presented in 
figure 1. 
Increased whole blood culture times alters relative expression of T cell cytokines. Considering that the 
kinetics of expression are not the same for all cytokines, it followed that optimal detection of a variety of 
cytokines might require modulating the length of the activation cultures. In particular, we speculated that Th2 
cytokines (such as IL-10) that are known to counter the inflammatory response and are expressed later in a 
typical immune reaction might not be optimally expressed at an early timepoint. A panel of Th1ffh2 cytokines 
(IFNg, IL-2, IL-10 and IL-4) were assessed for both culture conditions by flow cytometry at both an early (5 hour) 
and a later (24 hour) timepoint. The whole blood activation protocol described above was employed for this 
assay. For the 5-hour timepoint, mitogens and monensin were added to the cells simultaneously and incubated 
for 5 hours to allow cytokine accumulation. For the 24-hour timepoint, mitogens were added to the cells 
immediately and incubated for 24 hours, with monensin added for the final 5 hours to allow cytokine 
accumulation. We found that the expression of IFNg and IL-2 was consistently lower in the whole blood cultures 
which were allowed to progress to 24 hours of activation, however the expression of IL-10 was unaltered (or 
trending towards higher) in the 24 hour activation cultures (figure 2) . The expression of IL-4 did not achieve 
expression levels in most donors great enough to allow comparison of the two culture timepoints. Whole blood 
activation cultures allowed to progress past 24 hours contained substantial cellular debris and artifact, and were 
judged unsuitable for intracellular cytokine analysis (data not shown). 
Four color analysis allows phenotyping of cytokine producing T cells. A four-color analysis strategy was 
used to allow the assessment of two cytokines simultaneously in conjunction with two surface markers. This 
technique allowed phenotyping of responding T cells for two cytokines. The antibody combinations used for 
cytokine and surface marker staining are presented in table 1. Using these antibody combinations, well-defined 
analysis regions could be drawn around the lymphocytes, CD3+ T cells, CD8+ T cells and CD8- T cells. The 
legitimacy of assuming the CD3+/CDS- cells are analogous to the CD3+/CD4+ T cell population is addressed in 
the discussion. Representative scatter plots demonstrating the gating and cytokine analysis strategy are shown 
in figure 3. To demonstrate the utility of this technique, an analysis of cytokine production for the CD3+ T cell 
population in general, as well as the CDS+ and CDS- subsets was performed using the whole blood activation 
protocol at both the 5 hour and 24 hour timepoints. It was found that the expression of IFNywas significantly 
higher in the CD3+/CDS+ population as compared to the CD3+/CD8- population fOllowing 5 hours of activation. 
Conversely, the expression of both IL-2 and IL-10 was significantly higher in the CD3+/CD8- population as 
compared to the CD3+/CD8+ population (figure 4). The expression of IL-4 did not appear to be different 
between both T cell subsets, although in most of our healthy donors the expression was at such low levels that 
statistical comparisons were difficult. Increased detection of intracellular IL-4 in Th2 disease states (allergy, 
autoimmune disease, etc.) will most likely demonstrate clinical utility. The cytokine expression patterns and 
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statistical differences between the two T cell subsets were the same following 24 hours of whole blood activation 
as they were after 5 hours of whole blood activation (data not shown). 
Distinct cytokine-secreting monocyte subpopulations may be resolved using flow cytometry. To assess 
monocyte cytokine production patterns, either activation of PBMCs or whole blood for 24 hours was performed 
in the presence of 1 Oug/ml LPS. Nearly all of the peripheral monocytes were stimulated to secrete IL-1a in both 
culture systems. A distinct subpopulation of those monocytes were stimulated to secrete IL-12. In addition, 
following LPS activation, monocytes secreting IL-1 0 and TNFa were resolved, however IL-10 and TNFa 
secreting monocytes were largely distinct and mutually exclusive subpopulations (figure 5) . 
Monocyte IL-10 production is altered in whole blood culture. Levels of monocytes stimulated to secrete IL-
1 a, IL-12, TNFa and IL-1 0 were averaged for all subjects to assess alterations in expression patterns for whole 
blood activation. It was found that mean monocyte expression of IL-1a, IL-12 and TNFa was unaltered between 
PBMC and whole blood culture conditions. Interestingly, mean monocyte expression of IL-10 was significantly 
elevated following whole blood culture as compared to PBMC culture (Figure 6) . 
DISCUSSION 
The use of whole blood culture to perform cytokine flow cytometry was first described in 1997 (12-14) and again 
reported more recently by Tayebi et al. (15) . In these articles a protocol using diluted whole blood in culture to 
retain unfractionated cell populations and soluble plasma proteins was described. The ability to detect of 
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cytokines by flow cytometry was also demonstrated. Here, we have presented data regarding flow cytometric 
analysis of T cell and monocyte cytokine secreting sub-populations in the context of whole blood mitogenic 
stimulation, varied culture times and multicolor flow cytometry analysis. 
Regarding T cell cytokine secretion, 5 hour whole blood culture was found to result in significantly higher 
percentages of IFNy and IL-2 positive cells. The distribution of cytokine secretion was found to vary over time 
during whole blood culture, with IFNy and IL-2 significantly decreased at 24 hours (as compared to 5 hours) and 
IL -10 trending towards an increase. In addition, four-color T cell analysis was used to broaden the profile to 
include simultaneous Th1 and Th2 cytokines (IFN/IL-10 or IL-21IL-4) in conjunction with positively identified T 
cell subsets (CD3+/CD8+ and CD3+/CD8-) . This panel provides information regarding the Th1ITh2 balance of 
the individual T cell subsets. It is of note that proper identification of these T cell subsets will require dual 
staining of CD3 and CD8, since there are other cell populations in the blood which express CD8 (NK cell subset) 
and CD4 (monocytes). Differential expression of cytokine production by CD3+ T cell subsets was observed. 
The CD8+ T cell subset was found to be composed primarily of producers of IFNy, while the CD8- T cell subset 
was composed primarily of IL-2 producers. IL-10 was produced almost exclusively by the CD8- subset. 
Here, we have analyzed T cell cytokine production for the CD3+/CD8+ (suppressor/cytotoxic) and CD3+/CD8-
(helper/inducer) phenotypes. The assumption made was that the CD3+/CD8- T cell subset is largely analogous 
to the CD4+ T cell subset. The legitimacy of assuming the CD3+/CD8- population to be analogous to the CD4+ 
T cell population is controversial and has generated significant discussion. For our protocol this assumption 
was necessary for two reasons: (1) the CD4 molecule is internalized on T cells rapidly after PMNionomycin 
activation to nearly nondetectable surface levels and (2) to facilitate single-tube phenotyping and double-
cytokine analysis of both the CD4 and CD8 T cell subsets. A necessary assumption to utilize this method is that 
the CD3+/CD4+/CD8+ and the CD3+/CD4-/CD8- populations are negligible. Of course, in many disease states 
(such as HIV infection) this would not be the case and therefore this assumption would be invalid. Although the 
'normal ranges' for these phenotypes would have to be established for individual laboratories, it is the opinion of 
the authors that in healthy individuals these populations are in fact a negligible proportion of the T cell 
compartment. It is noteworthy that for mitogeniC stimuli other than PMNionomycin the internalization of CD4 is 
typically not a problem, however levels of cytokine producing cells induced by other stimuli are also typically not 
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as great as those induced by PMNionomycin. It is therefore highly desirable to stimulate cells with 
PMNionomycin in most cases to determine cytokine production profiles. 
Several alternatives to allow positive identification of CD4+ T cells following PMA+ionomycin activation have 
recently been suggested. These include prestaining CD4 prior to activation (16) and the staining (after 
activation) of intracellular CD4. For prestaining of CD4, it has been reported that the addition of monensin 
abrogates the protolytic effects of internalization and allows stable detection of CD4. The effects of prestaining 
CD4 on cellular activation would have to be determined for the experimental conditions. In disease states where 
positive identification of CD4 would be desired it is likely that staining intracellular CD4 with a bright 
fluorochrome would be the most successful option. Staining CD4 in addition to CD8 would require a separate 
analysis tube (when used with our two-cytokine four-color analysis system). If the assumption to assess 
CD3+/CD8- cells as the helper inducer subset is appropriate for the patient/donor population, the single tube 
dual cytokine/dual surface marker assay system described here would then have significant advantages. 
It is important to note that for T cell activation a higher level of PMA was used for whole blood culture (100 
ng/ml) than for PBMC culture (10 ng/ml). This is consistent with reports in the literature. In our preliminary work 
it was found that if the whole blood PMA level (100 ng/ml) were used in PBMC cultures, cell death resulted. If 
the PBMC PMA level (10 ng/ml) were used in whole blood cultures little to no activation occurred. The reason 
for this difference is unknown, but it remains clear that the whole blood condition (probably due to the presence 
of RBCs) require the use of the much higher PMA concentrations. It is possible that the higher cytokine 
production observed in the whole blood cultures is attributable to the elevated PMA concentration, but it is also 
possible that the presence of soluble serum factors or other cell types is responsible. It must be noted that the 
ultimate goal of cytokine flow cytometry is to drive as many cells as possible to their natural cytokine producing 
activation endpoint. Even if the elevated PMA concentration is responsible by allowing many more T cells to be 
activated, a clearer window to the cytokine bias of the peripheral immune system is the result. The monocyte 
data, where an equal level of LPS (10 j.!g/ml) was acceptable for use in both culture systems, argues in favor of 
either natural cell interactions or plasma factors influencing the whole blood cytokine profile outcome. 
Regarding monocyte cytokine secretion profiles, IL-12 producing monocytes were found to be a distinct 
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subpopulation of the whole, with the majority of the monocytes producing IL-1a.. Interestingly, TNFa. and IL-10 
secreting monocytes were resolved and found to be largely mutually exclusive. TNFa. and IL-10 secreting 
monocytes may thus represent largely exclusive monocyte subsets which may be distinguished based on 
cytokine secretion profiles. Cytokine production patterns were largely unchanged between whole blood and 
PBMC culture, with the notable exception of IL-10. Monocytes secreting IL-10 were significantly elevated in the 
whole blood culture. Since the level of LPS was the same for both culture conditions, the difference may be 
attributable to a soluble.plasma factor, or interaction with acell type eliminated during PBMC purification. 
In summary, the use of whole blood culture to assess the cytokine balance of the peripheral immune system 
appears to have several advantages and gives altered results as compared to PBMC culture techniques. The 
benefits of whole blood activation detailed here include: (1) the detection of larger percentages of IL -2 and I FNy 
producing T cells (as compared to PBMC activation); (2) potential increase in ability to detect T ce1l1L-10 
production (Th1 cytokines are downregulated, IL-10 trended towards upregulation) by increasing culture times; 
(3) the ability to determine the phenotype the T cell subsets responsible for dual cytokine production using 
multicolor analysis. For monocytes, in whole blood culture a significant bias towards IL-10 and a trend towards 
decreased TNFa production was observed. 
There are several mechanisms by which whole blood activation would more closely represent the in-vivo 
situation than would PBMC culture. They include: (1) retaining all cell populat ions present in the peripheral 
blood to maintain necessary cell-cell interactions; (2) retaining at dilution all soluble factors present in the 
plasma; (3) and retaining necessary activation antigens or secreted molecules from cells which are no longer 
present in PBMC culture. In addition to more accurately reflecting the in vivo situation, the use of whole blood 
activation is a rapid non-labor intensive protocol that may be compatible for routine monitoring of cytokine 
secretion patterns in clinical laboratories. 
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Figure Legends 
Figure 1. T celllFN and IL-2 production is altered in whole blood culture as compared to PBMC culture. PBMC 
stimulation was performed for 5 hours using 10 nglml PMA and 2 ug/ml ionomycin. Whole blood activation was 
performed using a 1 :20 dilution of whole blood in media containing 100 nglml PMA and 2 uglml ionomycin. 3 
uM mononsin was added to all cultures to abrogate extracellular transport and allow intracellular accumulation 
of cytokines. Error bars represent the standard error, mean of 7 experiments. Significant differences are 
indicated (*). 
Figure 2. Optimal T cell cytokine production in whole blood culture is time dependant. For all cytokines 
measured (with IL-10 an exception) 5 hour whole blood activation is sufficient for optimal production. IL-10 
expression is slightly elevated at 24 hours as compared to 5 hours. This result is consistently seen and fits with 
the role of IL-10 as a down regulator of the inflammatory response whose expression occurs late in the kinetics 
of an immune reaction. Error bars represent the standard error, mean of 6 experiments. Significant differences 
are indicated (*). 
Figure 3. Representative scatter plots demonstrating the gating and analysis strategy for four-color dual-
cytokine and phenotype T cell analysis by flow cytometry. (A) lymphocyte gate; (B) pan-T cell gate; (C) CD8+ 
and CD8- T cell gate; (D) T cell isotype control analysis; (E) and (F) IFNg/IL-10 analysis for T cell subsets; (G) 
and (H) IL-2IIL-4 analysis for T cell subsets. NOTE: The legitimacy of assuming the CD3+/CD8- population to 
be analogous to the T helper subset is discussed in the text. 
Figure 4. Differential expression of cytokines by T cell subsets. Whole blood cultures were activated for 5 
hours in media containing PMA+ionomycin+monensin and stained for surface phenotype and intracellular 
cytokines using the four-color analysis protocol described. Error bars represent the standard error (n=5) and 
significant differences are indicated (*). 
Figure 5. Representative scatter plots demonstrating the gating and analysis strategy for three-color dual-
cytokine monocyte analysis by flow cytometry. A typical (A) whole blood vs. (B) PBMC result for a healthy 
subject is presented. Note the presence of distinct granulocytes in the whole blood analysis, and their absence 
in the PBMC analysis. 
Figure 6. Mean percentages of monocytes expressing intracellular IL-1a, IL-12, TNFa and IL-10 demonstrate 
that cytokine production in whole blood culture is altered with respect to PBMC culture. PBMC stimulation was 
performed for 24 hours using 10 ug/ml LPS. Whole blood activation was performed for 24 hours using a 300 
~V2 . 0 ml dilution of whole blood in media containing 10 ug/ml LPS. 3 uM mononsin was added to all cultures for 
the final 5 hours to abrogate extracellular transport and allow intracellular accumulation of cytokines. Error bars 
represent the standard error, mean of 7 experiments. Significant differences are indicated (*) . 
--------- - -- - -- ---
Table 1: Four color antibody panel used for cytokine and surface marker analysis 
Tube 
1. 
2. 
3. 
4. 
5. 
6. 
FL1 
control* 
·IFNg* 
IL-2* 
control* 
IL-1<l 
TNFa# 
FL2 
control* 
IL-10# 
IL-4* 
control* 
IL-12# 
IL-10# 
FL3 FL4 
CD8 @ 
CD8 @ 
CDS@ 
CD14* 
CD14* 
CD14* 
FL 1: FITC; FL2: phycoerytherin; FL3: ECD; FL4: phJcoerytherin/cyan in5. *Becton-Dickinson, 
Mountain View, CA; #Pharmingin, San Diego, CA; Beckman-Coulter Corporation, Miami, 
FL. 
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